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ABSTRACT
Background: Liver storage diseases are rare biochemical and inherited diseases that af-
fect multiorgan systems.
Objectives: This study was performed to determine the rate of storage diseases and 
their types in liver pathology specimens of subjects who were referred to a tertiary 
pediatric center.
Patients and Methods: Two pathologists evaluated 2216 pathology specimens (stained 
with hematoxylin and eosin and periodic acid-Schiff) from subjects who were referred 
to the largest pediatric tertiary referral center in Iran between 1996 and 2007. Base-
line data and clinical and laboratory manifestations were retrieved from the patients’ 
files.
Results: We identified 117 patients who had storage diseases. A combination of clini-
cal and laboratory findings was used to assess the final diagnosis. Glycogen storage 
disease (GSD) was observed in 85 of cases, compared with lysosomal storage diseases 
(LSD) in 31 patients and mucopolysaccharidoses in 1 case. LSD was more prevalent in 
those aged between 1 month and 1 year, whereas GSD was more frequent in those aged 
between 1 and 6 years. Most of the patients aged between 1 and 6 years. Most patients 
with LSD and GSD had unknown types of the disease. The most common known types 
in the LSD and GSD groups were Niemann-Pick disease and GSD type I respectively. The 
most common clinical and laboratory manifestation was hepatomegaly and abnor-
mal liver enzymes, respectively.
Conclusions: Most of our patients with storage diseases had Gaucher disease. Hepatome-
galy and elevated transaminase levels were the most striking finding. However, with 
regard to the limitations of our methodology, further studies that collect more accu-
rate data are warranted.
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  Implication for health policy/practice/research/medical education:
There is no report of liver storage disease in Iran. This study is the first who report the results of ten years study of liver biopsies in a 
tertiary care center in Tehran-Iran. This article would be attractive for practitioners and researches who are interested in pediatrics, 
pediatric endocrinology and pediatric gastroenterology.
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1. Background
Liver storage diseases are rare biochemical and 
inherited diseases that affect multiorgan systems. These Hepat Mon. 2011;11(8):652-655
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diseases include lysosomal storage diseases (LSDs), 
mucopolysaccharidoses  (MPS),  and  glycogen  storage 
disease (GSD) (1-6). LSDs comprise at least 40 diseases 
that are caused by intralysosomal accumulation of 
compounds in a variety of cells. The prevalence of LSDs 
is 1 person per 5000 to 7000 in the Netherlands (7) and 
12.25 per 100,000 in the Czech Republic; lipidoses (55%) 
and MPSs (25%) are the most frequent. Gaucher disease 
has the highest prevalence among all types—1.13 per 
100,000 (8). The highest occurrence of LSDs was reported 
in the north of Portugal (9). LSDs include diseases, such as 
neuronal ceroid lipofuscinoses (NCL), sphingolipidoses 
(Gaucher disease, Niemann-Pick syndrome type A,B,C,..), 
mucopolysaccharidoses (I,II,…,VII), mucolipidoses 
(II,III,IV), oligosaccharidoses, silalidoses, and GSDII 
(Pompe disease).
Most  of  these  diseases  are  inherited  as  autosomal 
recessive traits, except MPSII (Hunter) and Fabry disease, 
which are X-linked (8). As mentioned above, MPSs are 
a  group  of  disorders  with  specific  lysosomal  enzyme 
deficiencies  that  are  caused  by  excess  accumulation 
of glycosaminoglycans. They have a wide spectrum of 
clinical presentations, due to the abundance of GAGs 
in connective tissues. Six types of MPS are known, the 
most  severe  of  which  is  MPS  I.  In  a  Czech  study,  MPS 
III had the highest prevalence of all MPSs (6). GSDs are 
caused by abnormalities in enzymes that organize 
the synthesis or degradation of glycogen. Type I is 
subdivided into Ia and Ib, and type III comprises the 
IIIa and IIIb subtypes; each of them has a deficiency in 
glycogen  metabolism  (6).  The  approximate  frequency 
of GSDs is 1 in 20,000 live births, and type I is most 
common in childhood. All are inherited as autosomal 
recessive disorders, except for phosphoglycerate kinase 
deficiency  and  one  form  of  phosphorylase  kinase 
deficiency, which are X-linked disorders. Hypoglycemia 
is a common primary manifestation in most of GSDs (1, 
10). Overall, the clinical and laboratory features of liver 
storage diseases are hypoglycemia, physical and mental 
retardation, changes in blood lactate, triglycerides, 
cholesterol , transaminases and uric acid, muscular 
problem, jaundice, glaucoma, neurologic, renal, or   
muscular  degeneration,  unexplained  hepatomegaly, 
splenomegaly, cardiomyopathy, and skeletal dysplasias 
and deformations (1-3, 5). There is no report of storage 
disease status in Iran.
2. Objectives
We  conducted  a  retrospective  study  to  evaluate  the 
pathology specimens of subjects who were referred to 
the largest tertiary pediatric referral center for storage 
diseases.
3. Patients and Methods
This  retrospective  study  was  conducted on liver 
pathology specimens from 2216 subjects between 1996 
and 2007. Participants included pediatric patients aged 
under 16 years who were referred to the largest tertiary 
pediatric referral center in Iran, with more than 6000 
admissions  annually.  Approximately  1000  patients 
are admitted our gastroenterology each year. The 
pathology  specimens  were  stained  with  hematoxylin 
and  eosin,  periodic  acid-Schiff  (PAS)  trichorom,  and 
PAS  with  diastase.  Two  expert  pathologists  evaluated 
the specimens for histopathological features of storage 
disease—namely GSD, LSD (Gaucher and Niemann-Pick), 
and MPS.
Patient data, such as age, sex, family history, and overall 
clinical features, were also extracted from patients’ files. 
Data  were  presented  as  number,  percentage,  mean, 
and range. A combination of clinical and laboratory 
findings  was  used  to  assess  the  final  diagnosis.  The 
presence  of  Kupffer  cells  with  wrinkled  cytoplasms, 
which  are  prominent  in  PAS  staining,  suggested  a 
diagnosis of Gaucher disease. The presence of large foam 
cells in sinusoids with a negative PAS stain was used as 
a  diagnostic  pathological  criterion  for  Niemann-Pick 
disease. Liver tissue with a swelled cytoplasm that was 
filled with pink material and closure of sinusoids by plant-
like swallowed hepatocytes suggested GSD. GSD Type I and 
Type III are PAS (+) and sensitive to diastase. Mild fibrosis 
is usually seen in GSD Type I and severe fibrosis is seen in 
GSD Type III, but it is difficult to distinguish severe Type I 
and Type III disease. In fact, immunohistochemical assay 
and genetic studies are needed to achieve a net diagnosis 
for liver storage diseases. Large, round hepatocytes with 
a ground-glass appearance are usually seen in Type 
IV.  Additionally,  PAS  (+)  and  diastase-resistant  pinkish 
material  that  is  surrounded  by  a  clear  space  (fixation 
artifact causing retraction of the cytoplasm from cell 
membrane) is a pathogenomonic pathologic feature 
of Type IV GSD. This study was approved by the ethical 
committee of Tehran University of Medical Sciences and 
conforms to the provisions of the Declaration of Helsinki 
(as revised in Edinburgh 2000). Although this study 
was retrospective and the data were extracted from the 
patients’ files at the time of biopsy, a consent form was 
obtained from the patients’ parents.
4. Results
Of the 2216 specimens that were evaluated for storage 
diseases, 117 had evidence of storage diseases. Seventy 
patients were males and 47 were females. Mean age was 
32.8  months.  There  was  no  case  aged  under  1  month. 
GSD was seen in 85 cases, LSD in 31 patients, and MPS in 
1 case. LSD was more prevalent in those aged between 1 
month and 1 year, whereas GSD was seen more often in 
those aged between 1 and 6 years. Most cases were aged 
between 1 and 6 years. Most patients with LSD and GSD had 
unknown types of the disease. The most common known 
types  in  the  LSD  and  GSD  groups  were  Niemann-Pick 
disease and GSD type I respectively. Detailed information 
on the distribution is presented in Table 1.Hepat Mon. 2011;11(8):652-655
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Total, No. 
(n = 117)
                      Age, mo Gender
1 – 12 12 - 72 > 72 Male (n = 70) Female (n = 47)
GSD a  85 17 58 10 - -
Type I 
Type IV
Unknown
18
3
64
4
1
12
13
2
43
1
-
5
13
1
32
5
2
32
LSD a  31 15 12 4 - -
Gaucher’s disease
Niemann Pick’s
Unknown
8
11
12
3
7
5
3
4
5
2
-
2
7
8
8
1
3
4
MPS a 1 - 1 - 1 -
Table 1. Age and Gender Distribution of Liver Storage Disease
a Abbreviations: GSD, glycogen storage disease; LSD, lysosomal storage disease; MPS, mucopolysaccharidoses
Seven patients (6%) suffering from storage disease had 
a positive family history for such diseases. 99 patients 
had negative family histories. Unfortunately the family 
histories  for  11  patients  were  unavailable.  The  most 
common manifestation was hepatomegaly, which was 
present  in  108  (92.3%)  patients;  39.3%  of  patients  had 
splenomegaly, 9.4% had seizure attacks, 5.1% had jaundice, 
and 5.1% had abnormal faces. Laboratory abnormalities 
were also prevalent in the patients. The most common 
laboratory  abnormality  was  elevated  transaminase 
levels, present in 90 (76.9%) patients. Only 1 patient had 
normal  aminotransferase  levels;  26  had  an  unknown 
liver  enzyme  status.  Hypoglycemia  was  present  in  23 
cases with GSD and no patients with LSD. Other abnormal 
findings are presented in Table 2.
5. Discussion
The  purpose  of  this  study  was  to  evaluate  liver 
pathology specimens of 2216 children who were referred 
to a children’s medical center for evidence of liver storage 
diseases. We found that 117 of them had storage diseases, 
of  which  GSD  was  the  most  common.  Hepatomegaly 
and  abnormal  liver  enzymes  were  the  most  common 
clinical  and  laboratory  findings,  respectively.  Most 
studies evaluate storage diseases specifically; i.e., based 
on their type. Most of our patients had GSD. Although 
studies on the prevalence of GSD (in general) are lacking, 
evidence on the prevalence of each type of GSD and LSD 
supports the finding of our study that GSD is generally 
more common than LSD (8). Our study noted a lower 
prevalence of Gaucher disease compared with Niemann-
Pick disease, which contrasts the finding of studies in 
the Netherlands (7) and Australia but similar to those in 
Portugal and the Czech Republic (8, 9). For example, in 
a study by Poupetova et al. in the Czech Republic, a total 
of 478 patients with LSD were identified, with lipoidosis, 
such as Niemann-Pick and Gaucher, as the most prevalent 
types (8). We only found 1 case with MPS, whereas they 
found 119 cases—25% of their sample. Although our 
patients were enrolled from all around our country, our 
study was not a prevalence study, and the findings can 
not be interpreted as those from a population based 
study.
Hepatomegaly  was  the  most  common  finding  in 
our  patients,  which  is  consistent  with  the  high  rate 
of liver involvement in both LSDs and GSDs. However, 
liver biopsies may bias this finding, because the liver 
must have been involved to have been included in our 
study.  Other  manifestations,  including  neurologicall 
abnormalities  and  dysmorphic  features,  were  also 
present in our patients, which is consistent with many 
studies (1, 2, 4, 5, 8, 10, 11). The laboratory findings of 
our study are consistent with several others, and it is 
not  surprising  that  hypoglycemia  was  not  observed 
in  LSD.  Again,  increased  liver  enzymes  were  the  most 
prevalent  laboratory  finding.  Other  studies,  however, 
separated the laboratory features of different kinds of 
storage  diseases,  based  on  their  type.  For  example,  in 
GSD type Ia, hypoglycemia and acidosis are the most 
striking features, rather than abnormal liver enzymes 
and features of liver failure, such as jaundice. In GSD type 
IV, abnormal transaminase is a prominent feature, along 
with hepatomegaly (10, 12). As another example, Gaucher 
Manifestation  Frequency, %
Hepatomegaly 92.3
Splenomegaly 39.3
Elevated aminotranferase 76.9
Elevated triglyceride or cholesterol  35
Abnormal coagulation profile 5.1
Jaundice 5.1
Seizure 9.4
Abnormal facial features 5.1
Metabolic acidosis 10.3
Hypoglycemia  19.7
Others a 29
Table 2. Manifestations of Storage Diseases (n = 117)
a Strabismus, cloudy cornea, pruritus, spider angioma, palmar erythema, 
fever and sweating, anemia, vomiting, respiratory distress, chronic diarrhea, 
kidney  problem,  abdominal  collateral  vessels,  ascites,  cirrhosis,  severe 
headache, myotoniaHepat Mon. 2011;11(8):652-655
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disease primarily involves bone and bone marrow, thus 
leading to cytopenia (13). The most important advantage 
of our study is its large sample size—recruited from 
the largest tertiary pediatric referral center. The other 
advantage was that our study was the first to address 
storage disease overall in Iran.
Our  study  had  several  limitations;  first,  the  design 
of the study was of a retrospective nature, which may 
potentially have caused recall bias and missing data. 
Second, immunohisctochemical assay and genetic 
studies are the mainstays of the diagnosis of storage 
diseases, unfortunately the design of the study based on 
the histopathologic diagnosis of the disease due to lack 
of the required technologies at the time of assessment, 
prevented the study from having high diagnostic 
value, particularly for those types of GSD that cannot 
be distinguished based on histopathological features. 
Third, the thesis on which the paper is based did not 
separate clinical presentation and laboratory studies 
based on the type of storage disease.
In conclusion, despite its retrospective nature and 
limitations, our study is the first to address storage 
diseases in Iran. GSD is the most prevalent storage disease, 
and hepatomegaly and abnormal liver enzymes are the 
most common abnormal findings. Further studies with 
more precise data that are preferably prospective in 
nature are required to give us a full picture of storage 
diseases in Iran.
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